Search for Clinical Trial Results
Prurigo - 17 Studies Found
Status | Study |
Completed |
Study Name: Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis Condition: Prurigo Nodularis Date: 2007-09-19 Interventions: Drug: citalopram (cipralex) 10-20 mg/day, for 12 weeks. |
Active, not recruiting |
Study Name: Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis Condition:
|
Completed |
Study Name: Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease Condition: Prurigo Nodularis Date: 2007-07-26 Interventions:
|
Completed |
Study Name: Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis Condition:
|
Not yet recruiting |
Study Name: Dapsone Prurigo Study Condition: Lichen Simples Chronicus and Prurigo Date: 2013-06-03 Interventions: Drug: Dapsone gel - verum Other Name: aczone gel |
RECRUITING |
Study Name: A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) Condition: Prurigo Date: 2024-05-10 Interventions: Ruxolitinib cream 1.5% twice daily (BID) during the vehicle controlled (DBVC)and open label treatment period (OLE). |
RECRUITING |
Study Name: A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) Condition: Prurigo Nodularis Date: 2024-05-10 Interventions: Ruxolitinib cream 1.5% twice daily (BID) during the continuous and open label treatment period. |